RESMED INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Resmed Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q3 2024.
  • Resmed Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was -$151M, a 0.25% increase year-over-year.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$1.12B, a 365% decline from 2023.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $423M.
  • Resmed Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$128M, a 83.2% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$151M +$375K +0.25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q3 2023 -$151M -$109M -261% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q3 2022 -$41.9M -$135M -145% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q3 2021 $93M +$268M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q3 2020 -$175M -$75.2M -75.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q3 2019 -$100M -$245M -169% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q3 2018 $145M +$251M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q3 2017 -$106M Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q3 2012 $7.69M +$91.6M Jul 1, 2012 Sep 30, 2012 10-Q 2012-10-31
Q3 2011 -$83.9M -$47.5M -130% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q3 2010 -$36.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.